Randomized, Double-Blinded, Multicenter, Placebo-Controlled Trial of Shenfu Injection for Treatment of Patients with Chronic Heart Failure during the Acute Phase of Symptom Aggravation (Yang and Qi Deficiency Syndrome)

<table class="fixed-width table-group" id="tab6"><tr><td><table class="table"><colgroup><col style="width:5.05em"/><col style="width:13.81em"/><col style="width:5.58em"/><col style="width:7.43em"/><col style="width:4.18em"/></colgroup><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr class="thead"><td class="align_left">Endpoint</td><td class="align_center"> </td><td class="align_center">SFI (n=72)</td><td class="align_center">Placebo (n=67)</td><td class="align_center">P value</td></tr><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr><td class="align_left">LVEF</td><td class="align_center">Post-treatment – pre-treatment</td><td class="align_center">6.58±9.11</td><td class="align_center">4.53±8.21</td><td class="align_center">0.2347</td></tr><tr class="table-tr"><td colspan="5"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Comparison of change in LVEF (pre-to-post treatment) between SFI and placebo groups.</div>

Evidence-Based Complementary and Alternative Medicine

tab6

Table 6

Table 6: Randomized, Double-Blinded, Multicenter, Placebo-Controlled Trial of Shenfu Injection for Treatment of Patients with Chronic Heart Failure during the Acute Phase of Symptom Aggravation (Yang and Qi Deficiency Syndrome) 

Table 6 | Randomized, Double-Blinded, Multicenter, Placebo-Controlled Trial of Shenfu Injection for Treatment of Patients with Chronic Heart Failure during the Acute Phase of Symptom Aggravation (Yang and Qi Deficiency Syndrome) 